DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”
In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs
DCT Board Approves Concepts For New RFA, New And Recompeting Contracts
Major Changes In NCI Drug screening Tumor Panels Approved
Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal
Ethics Commission Say HHS Should Test Injury Compensation
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









